Insulet Corporation (NASDAQ:PODD) is one of the best NASDAQ growth stocks to buy for the next 5 years. On October 10, RBC Capital raised the price target on Insulet to $365 from $350 and kept an Outperform rating on the shares as part of a broader research note on the MedTech sector ahead of Q3 2025 results due to attractive valuations and numerous opportunities in the Medical Supplies & Devices sector. RBC Capital is particularly bullish on Insulet. Investor sentiment is positive ahead of the company’s Q ...